Needle-Free Injection System Market Professional Survey Report 2019

According to Latest Market research report Published by MarketsandMarkets the “Needle-Free Injection System Market Size, Share, Demand and Growth Analysis, forecast” the Global Market is expected to reach $ 20.17 billion, at a CAGR of 15.5%

Growth in this market is mainly driven by the growing prevalence of the chronic disease, increasing the incidence of communicable disease due to needlestick injuries, rising demand for biosimilars and vaccination, advantages of drug delivery technology, increasing demand for self-injection devices.

Download PDF Brochure:

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=165815861

key players operating in the Global Needle-Free Injection System Market;

Companies are focusing on adopting organic as well as inorganic growth strategies such as acquisition, agreements, collaboration, expansion, product upgrades, partnerships, and others (approvals and certifications) to synergistically offer advanced needle-free injection solutions in the market

Key market players include Antares Pharma, Inc. (U.S.), Endo International plc (U.S.), PharmaJet (U.S), Bioject Medical Technologies Inc. (U.S), Medical International Technology, Inc. (U.S), INJEX Pharma AG (Germany), National Medical Products Inc. (U.S.), Valeritas, Inc. (U.S.), European Pharma Group (Netherland), PenJet Corporation (U.S), Crossject SA (France).

Major Drivers Impacting the Needle-Free Injection System Market;

· Growing Prevalence of Chronic Diseases

· Increasing Incidence of Communicable Diseases Due to Needlestick Injuries

· Rise in Demand for Self-Injection Devices

· Rising Demand for Biosimilars and Vaccination

Request Research Sample Pages:

https://www.marketsandmarkets.com/requestsampleNew.asp?id=165815861

Global Needle-Free Injection System Market Segmentation:

Based on the technology, the market is divided into Jet-based needle-free injectors, spring-based needle-free injectors, laser-based needle-free injectors, and vibration-based needle-free injectors. The jet-based needle-free injectors are expected to witness the highest growth during the forecast period, due to their advantages over the other injector systems.

Global Needle-Free Injection System Market, by type of Medication

• Liquid-based needle-free injectors
• Powder-based needle-free injectors
• Projectile/depot-based needle-free injectors

Global Needle-Free Injection System Market, by Application

• Vaccine Needle-free delivery
• Insulin Needle-free delivery
• Pain Management Needle-free delivery
• Oncology Needle-free delivery

Needle-Free Injection System Market | Growth Drivers | Restraints | Opportunities and Trends

According to a new market research report “Needle-Free Injection System Market by Product (Fillable, Prefilled), by Technology (Jet, Spring, Laser, Vibration), Usability (Reusable, Disposable), Type of Medication (Liquid, Depot), Delivery Site (Intramuscular, Subcutaneous) — Forecasts ”, published by MarketsandMarkets

Growth in this market is mainly driven by the growing prevalence of the chronic disease, increasing the incidence of communicable disease due to needlestick injuries, rising demand for biosimilars and vaccination, advantages of drug delivery technology, increasing demand for self-injection devices.

Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=165815861

Based on the technology, the Needle-Free Injection System Market is divided into Jet-based needle-free injectors, spring-based needle-free injectors, laser-based needle-free injectors, and vibration-based needle-free injectors. The jet-based needle-free injector is expected to account for the largest market share in 2016, due to their advantages over the other injector systems.

Based on the Applications, the Needle-Free Injection System Market is segmented into vaccine delivery, insulin delivery, Oncology, pain management, and other applications; the vaccine delivery application segment is projected to be the fastest-growing segment during the forecast period in 2016. The growth of this market primarily attributed to factors such as the rising incidence of chronic diseases, technological advancement, and growing preference for self-medication.

Based on the end user, the Needle-Free Injection System Market is segmented into Hospitals and Clinics, home care settings, research laboratories, pharmaceutical and biotechnological companies and another end user. The hospitals and clinics segment are expected to grow at the highest rate in the forecast period. The growth in this segment can primarily be attributed to the advancement in the medication or drug delivery technology and rising geriatric population.

Request Research Sample Pages:https://www.marketsandmarkets.com/requestsampleNew.asp?id=165815861

Geographical Analysis:

The Needle-Free Injection System Market is dominated by North America, followed by Europe, Asia, and the Rest of the World. While North America is expected to dominate the market. Europe is expected to grow at the highest CAGR during the forecast period. The high growth in this market is attributed to the rising demand for biologics, growing prevalence of chronic diseases, technological advancements, mergers and acquisitions by major companies in the market, favorable reimbursement policies, increasing healthcare expenditure and regulatory approvals of new injection system are key factors driving the market growth in Europe

The Needle Free Injection System Market is a fragmented market, with several big and emerging players.Key market players include Antares Pharma, Inc. (U.S.), Endo International plc (U.S.), PharmaJet (U.S), Bioject Medical Technologies Inc. (U.S), Medical International Technology, Inc. (U.S), INJEX Pharma AG (Germany), National Medical Products Inc. (U.S.), Valeritas, Inc. (U.S.), European Pharma Group (Netherland), PenJet Corporation (U.S), Crossject SA (France).